Risk Factor

Alive (n = 70)

Deceased (n = 4)

P

Age (in years)

29 (11 - 43)

30 (8 - 64)

0.09

Female gender n (%)

29 (41.4)

3 (75)

0.299

Functional stage III-IV n (%)

20 (28.6)

4 (100)

0.022

chest pain n (%)

7 (10)

1 (25)

0.21

exertional hepatalgia n (%)

17 (2.4)

2 (50)

0.16

cough n (%)

15 (2.1)

1 (25)

0.41

Hepatomegaly n (%)

65 (92.8)

4 (100)

0.35

Hepato jugular reflux n (%)

64 (91.4)

4 (100)

0.35

Edema of the lower limbs n (%)

63 (90)

4 (100)

0.33

Ascites n (%)

60 (85.7)

4 (100)

0.27

Spontaneous turgidity of the jugular veins n (%)

47 (67.1)

4 (100)

0.35

Collateral venous circulation n (%)

43 (61.4)

4 (100)

0.07

Pleural effusion n (%)

44 (62.8)

2 (50)

0.31

Splenomegaly n (%)

2 (2.9)

1 (25)

0.08

Fever n (%)

2 (2.9)

1 (25)

0.08

Facial puffiness n (%)

1 (1.4)

1 (25)

0.054

Alteration of general condition n (%)

1 (1.4)

1 (25)

0.054

Jaundice n (%)

1 (1.4)

1 (25)

0.054

mean cardiothoracic ratio (mean)

0.51 ± 0.033

0.50 ± 0.012

0.119

Pericardial calcifications n (%)

39 (55.7)

3 (75)

0.256

atrial fibrillation n (%)

12 (17.1)

2 (50)

0.089

peripheral micro-voltage n (%)

28 (40)

1 (25)

0.308

Pericardial effusion n (%)

21 (30)

0 (0)

0.127

The mean ejection fraction (mean)

0.58 ± 0.07

0.54 ± 0.04

0.138

RVEDP (mean)

19.6 (8 - 34)

16.8 (15 - 37)

0.12